Is there any evidence that this extra burden is producing better results.
There will be evidence, as many qualifications have to issue deviations for software/hardware/operator malfunctions.
The cost burden is passed onto clients, and there should be increased profits as turnover increases, but the increased administrative overhead often negates that potential.
My question would be; " Is this onerous operation providing effective utilisation of resources?".
The answers will vary, but I've been employed in a company that spent so much time building and maintaining large cGxP quality systems that they didn't deliver products to their clients in a cost-effective and timely manner, and were eventually closed down after the clients went elsewhere.
There are some wonderful quality people out there who know how to build simple, low-maintenance systems that encourge workers to initiate improvements, but the vast majority of quality people in the pharmaceutical industry seem to have the school prefect mentality.
The problem with almost all quality systems is that they can't address the fundamental issue of whether the process and product are the most cost-effective and appropriate solutions for the client. That applies to analytical protocols as much as it does to manufacturing.
Bruce Hamilton